Garg, Abhishek D.

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.

Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation

Cell death mechanisms and regulationAutophagy in Disease and Therapy

Cited by 6,680

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy

Autophagy in Disease and TherapyCalcium signaling and nucleotide metabolism

Cited by 5,894

Immunogenic cell death and DAMPs in cancer therapy

Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer

Cell death mechanisms and regulationImmunotherapy and Immune Responses

Cited by 3,223

EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research

EV-TRACK Consortium, Van Deun, J., Mestdagh, P., Agostinis, P., Akay, Ö., Anand, S., Anckaert, J., Martinez, Z. A., Baetens, T., Beghein, E., et al. (2017) · Nature Methods

Extracellular vesicles in diseaseAcademic Publishing and Open Access

Cited by 1,284

A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer

Bassez, A., Vos, H., Van Dyck, L., Floris, G., Arijs, I., Desmedt, C., Boeckx, B., Vanden Bempt, M., Nevelsteen, I., Lambein, K., et al. (2021) · Nature Medicine

Cancer Immunotherapy and BiomarkersBreast Cancer Treatment Studies

Cited by 867

Consensus guidelines for the detection of immunogenic cell death

Kepp, O., Senovilla, L., Vitale, I., Vacchelli, E., Adjemian, S., Agostinis, P., Apetoh, L., Aranda, F., Barnaba, V., Bloy, N., et al. (2014) · OncoImmunology

Immunotherapy and Immune ResponsesCell death mechanisms and regulation

Cited by 832

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., et al. (2012) · The EMBO Journal

Endoplasmic Reticulum Stress and DiseaseCell death mechanisms and regulation

Cited by 800

Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation

Krysko, D. V., Agostinis, P., Krysko, O., Garg, A. D., Bachert, C., Lambrecht, B. N., & Vandenabeele, P. (2011) · Trends in Immunology

Immune Response and InflammationInflammasome and immune disorders

Cited by 680

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy

Schaaf, M. B., Garg, A. D., & Agostinis, P. (2018) · Cell Death & Disease

Angiogenesis and VEGF in CancerCancer Immunotherapy and Biomarkers

Cited by 629

Integrating next-generation dendritic cell vaccines into the current cancer immunotherapy landscape

Garg, A. D., Coulie, P. G., Van den Eynde, B. J., & Agostinis, P. (2017) · Trends in Immunology

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 340

ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death

Garg, A. D., Dudek, A. M., Ferreira, G. B., Verfaillie, T., Vandenabeele, P., Krysko, D. V., Mathieu, C., & Agostinis, P. (2013) · Autophagy

Autophagy in Disease and TherapyPhotodynamic Therapy Research Studies

Cited by 305

Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity

Garg, A. D., Nowis, D., Golab, J., & Agostinis, P. (2010) · Apoptosis

Photodynamic Therapy Research StudiesImmunotherapy and Immune Responses

Cited by 297

Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma

Garg, A. D., Vandenberk, L., Koks, C., Verschuere, T., Boon, L., Van Gool, S. W., & Agostinis, P. (2016) · Science Translational Medicine

Immunotherapy and Immune ResponsesGlioma Diagnosis and Treatment

Cited by 270

Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity

Vanderbeke, L., Van Mol, P., Van Herck, Y., De Smet, F., Humblet-Baron, S., Martinod, K., Antoranz, A., Arijs, I., Boeckx, B., Bosisio, F. M., et al. (2021) · Nature Communications

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 247

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy

Adkins, I., Fucikova, J., Garg, A. D., Agostinis, P., & Špíšek, R. (2014) · OncoImmunology

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 200

Type I interferons and dendritic cells in cancer immunotherapy

Sprooten, J., Agostinis, P., & Garg, A. D. (2019) · International Review of Cell and Molecular Biology

Immunotherapy and Immune Responsesinterferon and immune responses

Cited by 124

Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing

Garg, A. D., Vandenberk, L., Fang, S., Fasche, T., Van Eygen, S., Maes, J., Van Woensel, M., Koks, C., Vanthillo, N., Graf, N., et al. (2017) · Cell Death & Differentiation

Neutrophil, Myeloperoxidase and Oxidative MechanismsImmune Response and Inflammation

Cited by 120

Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal

Garg, A. D., Elsen, S., Krysko, D. V., Vandenabeele, P., de Witte, P., & Agostinis, P. (2015) · Oncotarget

Immunotherapy and Immune ResponsesCell death mechanisms and regulation

Cited by 87

Type I interferons and endoplasmic reticulum stress in health and disease

Sprooten, J., & Garg, A. D. (2020) · International Review of Cell and Molecular Biology

interferon and immune responsesEndoplasmic Reticulum Stress and Disease

Cited by 83

Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer

Borràs, D. M., Verbandt, S., Ausserhofer, M., Sturm, G., Lim, J., Verge, G. A., Vanmeerbeek, I., Laureano, R. S., Govaerts, J., Sprooten, J., et al. (2023) · Cell Discovery

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 67

Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells

Martin, S., Dudek-Perić, A. M., Maes, H., Garg, A. D., Gabrysiak, M., Demirsoy, S., Swinnen, J. V., & Agostinis, P. (2015) · Biochemical Pharmacology

Melanoma and MAPK PathwaysAutophagy in Disease and Therapy

Cited by 54

Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity

Garg, A. D., Dudek, A. M., & Agostinis, P. (2013) · OncoImmunology

Autophagy in Disease and TherapyImmunotherapy and Immune Responses

Cited by 42